FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3197737106> ?p ?o ?g. }

• W3197737106 endingPage "2697" @default.
• W3197737106 startingPage "2687" @default.
• W3197737106 abstract "Methylnaltrexone inhibits opioid-induced constipation (OIC) by binding to peripheral µ-opioid receptors without impacting central opioid receptor mediated analgesia. This analysis compared methylnaltrexone efficacy and safety among advanced illness patients with and without active cancer and OIC.This post hoc analysis included two multicenter, randomized, double-blind, placebo-controlled studies in adults with advanced illness and OIC who received subcutaneous methylnaltrexone. Efficacy endpoints included the proportion of patients achieving rescue-free laxation (RFL), time to RFL, weekly laxations within 24 hours after dosing, rescue laxative use, and pain scores. Adverse events were monitored for safety.After pooling, 178 patients received methylnaltrexone (n = 116 with cancer) and 185 received placebo (n = 114 with cancer). Median baseline daily opioid morphine equivalents (mg/d) were higher in cancer (methylnaltrexone: 180; placebo: 188) versus noncancer patients (methylnaltrexone: 120; placebo: 80). The proportions of patients achieving RFL within 4 hours after ≥2 of the first 4 doses were significantly greater with methylnaltrexone (cancer: 56.9%; noncancer: 58.1%) versus placebo (cancer: 5.3%; noncancer: 11.3%; P < 0.0001). The median time to laxation within 24 hours after the first methylnaltrexone dose was significantly shorter in cancer and noncancer patients versus placebo (cancer: 0.96 vs 22.53 hours, P < 0.0001; noncancer: 1.25 vs >24 hours, P = 0.0002). The mean number of weekly laxations within 24 hours after dosing by week 2 was significantly higher in methylnaltrexone- vs placebo-treated cancer and noncancer patients (cancer: 7.9 vs 4.9, P < 0.0001; noncancer: 8.4 vs 5.0, P < 0.0001). Methylnaltrexone reduced rescue laxative use without impacting pain scores. Consistent with previous data, methylnaltrexone was well tolerated in cancer and noncancer patients, and the AE profile did not suggest symptoms of opioid withdrawal.Methylnaltrexone reduced RFL time in advanced-illness patients with and without active cancer, while maintaining pain control with opioid treatment despite higher baseline opioid use among cancer patients." @default.
• W3197737106 created "2021-09-13" @default.
• W3197737106 creator A5002994397 @default.
• W3197737106 creator A5013108068 @default.
• W3197737106 creator A5034299728 @default.
• W3197737106 creator A5035384537 @default.
• W3197737106 creator A5059512893 @default.
• W3197737106 date "2021-09-01" @default.
• W3197737106 modified "2023-09-27" @default.
• W3197737106 title "Subcutaneous Methylnaltrexone for Treatment of Opioid-Induced Constipation in Cancer versus Noncancer Patients: An Analysis of Efficacy and Safety Variables from Two Studies" @default.
• W3197737106 cites W1924169910 @default.
• W3197737106 cites W1935485911 @default.
• W3197737106 cites W1961278841 @default.
• W3197737106 cites W1979282061 @default.
• W3197737106 cites W1987755130 @default.
• W3197737106 cites W2001706478 @default.
• W3197737106 cites W2011776892 @default.
• W3197737106 cites W2014871043 @default.
• W3197737106 cites W2016491944 @default.
• W3197737106 cites W2017869035 @default.
• W3197737106 cites W2020500184 @default.
• W3197737106 cites W2021543354 @default.
• W3197737106 cites W2040109649 @default.
• W3197737106 cites W2075798150 @default.
• W3197737106 cites W2103918964 @default.
• W3197737106 cites W2110791210 @default.
• W3197737106 cites W2128539850 @default.
• W3197737106 cites W2139995836 @default.
• W3197737106 cites W2141948807 @default.
• W3197737106 cites W2151003241 @default.
• W3197737106 cites W2154781005 @default.
• W3197737106 cites W2164341191 @default.
• W3197737106 cites W2337210803 @default.
• W3197737106 cites W2396215196 @default.
• W3197737106 cites W2406100280 @default.
• W3197737106 cites W2517403006 @default.
• W3197737106 cites W2563316401 @default.
• W3197737106 cites W2588766647 @default.
• W3197737106 cites W2597056390 @default.
• W3197737106 cites W2786188339 @default.
• W3197737106 cites W2793222177 @default.
• W3197737106 cites W2883116867 @default.
• W3197737106 cites W2894672393 @default.
• W3197737106 cites W2904455780 @default.
• W3197737106 cites W2924701701 @default.
• W3197737106 cites W2985670640 @default.
• W3197737106 cites W2991421803 @default.
• W3197737106 doi "https://doi.org/10.2147/jpr.s312731" @default.
• W3197737106 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8420564" @default.
• W3197737106 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34512008" @default.
• W3197737106 hasPublicationYear "2021" @default.
• W3197737106 type Work @default.
• W3197737106 sameAs 3197737106 @default.
• W3197737106 citedByCount "3" @default.
• W3197737106 countsByYear W31977371062023 @default.
• W3197737106 crossrefType "journal-article" @default.
• W3197737106 hasAuthorship W3197737106A5002994397 @default.
• W3197737106 hasAuthorship W3197737106A5013108068 @default.
• W3197737106 hasAuthorship W3197737106A5034299728 @default.
• W3197737106 hasAuthorship W3197737106A5035384537 @default.
• W3197737106 hasAuthorship W3197737106A5059512893 @default.
• W3197737106 hasBestOaLocation W31977371061 @default.
• W3197737106 hasConcept C121608353 @default.
• W3197737106 hasConcept C126322002 @default.
• W3197737106 hasConcept C142724271 @default.
• W3197737106 hasConcept C170493617 @default.
• W3197737106 hasConcept C197934379 @default.
• W3197737106 hasConcept C204787440 @default.
• W3197737106 hasConcept C27081682 @default.
• W3197737106 hasConcept C2781063702 @default.
• W3197737106 hasConcept C2781112942 @default.
• W3197737106 hasConcept C42219234 @default.
• W3197737106 hasConcept C71924100 @default.
• W3197737106 hasConceptScore W3197737106C121608353 @default.
• W3197737106 hasConceptScore W3197737106C126322002 @default.
• W3197737106 hasConceptScore W3197737106C142724271 @default.
• W3197737106 hasConceptScore W3197737106C170493617 @default.
• W3197737106 hasConceptScore W3197737106C197934379 @default.
• W3197737106 hasConceptScore W3197737106C204787440 @default.
• W3197737106 hasConceptScore W3197737106C27081682 @default.
• W3197737106 hasConceptScore W3197737106C2781063702 @default.
• W3197737106 hasConceptScore W3197737106C2781112942 @default.
• W3197737106 hasConceptScore W3197737106C42219234 @default.
• W3197737106 hasConceptScore W3197737106C71924100 @default.
• W3197737106 hasLocation W31977371061 @default.
• W3197737106 hasLocation W31977371062 @default.
• W3197737106 hasLocation W31977371063 @default.
• W3197737106 hasOpenAccess W3197737106 @default.
• W3197737106 hasPrimaryLocation W31977371061 @default.
• W3197737106 hasRelatedWork W1947591645 @default.
• W3197737106 hasRelatedWork W1971671270 @default.
• W3197737106 hasRelatedWork W1977915442 @default.
• W3197737106 hasRelatedWork W2064879719 @default.
• W3197737106 hasRelatedWork W2085830368 @default.
• W3197737106 hasRelatedWork W2766008196 @default.
• W3197737106 hasRelatedWork W2797722903 @default.
• W3197737106 hasRelatedWork W3009301004 @default.
• W3197737106 hasRelatedWork W4233016836 @default.

• next